• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.91% Nasdaq Down1.38%

    Myriad Genetics Inc. (MYGN)

    -NasdaqGS
    38.25 Up 0.25(0.66%) 2:12PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue 189,884   179,986   184,393   168,837  
    Cost of Revenue38,389  36,294  37,852  34,865  
    Gross Profit 151,495   143,692   146,541   133,972  
    Operating Expenses
    Research Development18,712  16,672  17,504  22,612  
    Selling General and Administrative96,585  91,280  92,695  85,440  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 36,198   35,740   36,342   25,920  
    Income from Continuing Operations
    Total Other Income/Expenses Net(682)(174)1,599  (43)
    Earnings Before Interest And Taxes35,516  35,566  37,941  25,877  
    Interest Expense -   -   -   -  
    Income Before Tax35,516  35,566  37,941  25,877  
    Income Tax Expense16,804  14,091  13,910  9,895  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops18,712  21,475  24,031  15,982  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 18,712   21,475   24,031   15,982  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 18,712   21,475   24,031   15,982  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.